APA

Deconinck E., Cahn J. Y., Milpied N., Jouet J. P., Vernant J. P., Esperou H., Lioure B., Bordigoni P., Leblond V., Troussard X., Caillot D., Cordonnier J. M. & Hervé P. (19971230). Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). : Bone marrow transplantation.

Chicago

Deconinck E, Cahn J Y, Milpied N, Jouet J P, Vernant J P, Esperou H, Lioure B, Bordigoni P, Leblond V, Troussard X, Caillot D, Cordonnier J M and Hervé P. 19971230. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). : Bone marrow transplantation.

Harvard

Deconinck E., Cahn J. Y., Milpied N., Jouet J. P., Vernant J. P., Esperou H., Lioure B., Bordigoni P., Leblond V., Troussard X., Caillot D., Cordonnier J. M. and Hervé P. (19971230). Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). : Bone marrow transplantation.

MLA

Deconinck E, Cahn J Y, Milpied N, Jouet J P, Vernant J P, Esperou H, Lioure B, Bordigoni P, Leblond V, Troussard X, Caillot D, Cordonnier J M and Hervé P. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan). : Bone marrow transplantation. 19971230.